Structural analysis of CNPY2 interaction with UBE2D1 is required to improve our understanding of how CNPY2 inhibits MYLIP-UBE2D1 interaction, which may lead to development of new targeted therapy for cancer. The gene discussed is UBE2D1; the disease is cancer.